OnCovid [COVID-19]
Research type
Research Study
Full title
ONCOVID: natural history and outcomes of cancer patients during the COVID19 epidemic.
IRAS ID
282140
Contact name
David Pinato
Contact email
Sponsor organisation
Imperial College London
Eudract number
n/a
ISRCTN Number
n/a
Clinicaltrials.gov Identifier
n/a
Duration of Study in the UK
2 years, 0 months, 1 days
Research summary
The coronavirus spread is likely to affect millions of people in the world. Older people of people with medical problems are at risk of developing severe coronavirus illness, leading to a higher risk of death.\nPatients with cancer often have a weaker immune system either because of their cancer or because of treatment. We have little data to explain how patients with cancer fare when they have coronavirus. With this project we intend to check how coronavirus spreads, presents and affects the outcome of patients with cancer.
REC name
N/A
REC reference
N/A